OmeCare Competitors and Similar CompaniesClear all
OmeCare's competitors and similar companies include Blueprint Genetics and 23andMe.
 OmeCare OmeCare (formerly known as Pathway Genomics) is a clinical diagnostic and mobile healthcare technology company. |  Blueprint Genetics Blueprint Genetics provides clinical gene testing and customized next-generation sequencing services. |  23andMe 23andMe Holding (formerly known as VG Acquisition) is a consumer genetics and research company. | |
Founding Date | Founding Date 2009 | Founding Date 2012 | Founding Date 2006 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ San Diego, US | Locations Esbo, FI HQ Dubai, AE Seattle, US | Locations Sunnyvale, US HQ South San Francisco, US |
Employees | Employees 6 | Employees 2191% decrease | Employees 56027% decrease |
Valuation ($) | Valuation ($) 932.7 m | Valuation ($) N/A | Valuation ($) 169.1 m |
Financial | |||
Revenue (est.) | Revenue (est.) $14.4m (FY, 2013) | Revenue (est.) N/A | Revenue (est.) $189.9m (FY, 2025) |
Operating ⚠ | |||
Countries | Countries 40 (Jan, 2018) | Countries N/A | Countries 50 (Apr, 2020) |
Funding | |||
Total funding raised | Total funding raised $ 127.2m | Total funding raised $ 26.3m | Total funding raised $ 912.5m |
For sources of this data, please see the company profile
View Company Profiles
Blueprint Genetics
HQ
Esbo, FI
Employees
219↓ 1% decrease
Blueprint Genetics provides clinical gene testing and customized next-generation sequencing services.
View company23andMe
HQ
Sunnyvale, US
Employees
560↓ 27% decrease
23andMe Holding (formerly known as VG Acquisition) is a consumer genetics and research company.
View company